DICE Therapeutics, Inc. (DICE) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 48 transactions totaling $238.1M, demonstrating a bearish sentiment with -$6.1M in net insider flow. The most recent transaction on Aug 9, 2023 involved a transaction of 147,497 shares valued at $0.
No significant insider buying has been recorded for DICE in the recent period.
No significant insider selling has been recorded for DICE in the recent period.
Based on recent SEC filings, insider sentiment for DICE is bearish with an Insider Alignment Score of 49/100 and a net flow of -$6.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at DICE Therapeutics, Inc. (DICE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading DICE stock, having executed 48 transactions in the past 90 days. The most active insider is Ventures Ii, Lp Northpond (Executive), who has made 2 transactions totaling $115.9M.
Get notified when executives and directors at DICE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | R. Jacobsen John | Executive | Disposition | 147,497 | $N/A | $0 | |
| Aug 9, 2023 | Judice Kevin | Executive | Disposition | 799,685 | $N/A | $0 | |
| Aug 9, 2023 | Timothy Lu | Executive | Disposition | 152,285 | $N/A | $0 | |
| Aug 9, 2023 | H. Scheller Richard | Executive | Disposition | 8,427 | $N/A | $0 | |
| Aug 9, 2023 | M. Robertson Scott | Executive | Disposition | 198,000 | $N/A | $0 | |
| Aug 9, 2023 | Paul Scopa James | Executive | Disposition | 15,199 | $N/A | $0 | |
| Aug 9, 2023 | Paul Scopa James | Executive | Disposition | 25,722 | $N/A | $0 | |
| Aug 9, 2023 | Tetlow Sharon | Executive | Disposition | 49,841 | $N/A | $0 | |
| Aug 9, 2023 | Healthcare Fund Lp Ra Capital | Executive | Tender | 786,407 | $N/A | $0 | |
| Aug 9, 2023 | Healthcare Fund Lp Ra Capital | Executive | Tender | 7,070,205 | $N/A | $0 | |
| Aug 2, 2023 | Paul Scopa James | Executive | Gift | 220 | $N/A | $0 | |
| Aug 2, 2023 | Paul Scopa James | Executive | Gift | 2,200 | $N/A | $0 | |
| Jul 18, 2023 | Paul Scopa James | Executive | Gift | 2,200 | $N/A | $0 | |
| Jul 11, 2023 | Paul Scopa James | Executive | Gift | 300 | $N/A | $0 | |
| Jun 22, 2023 | Ii, Lp Northpond Ventures | Executive | Sale | 523,503 | $46.50 | $24.3M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 13 | $122.1M | 51.3% |
Purchase(P) | 11 | $116.0M | 48.7% |
Disposition(D) | 8 | $0 | 0.0% |
Tender(U) | 2 | $0 | 0.0% |
Gift(G) | 10 | $0 | 0.0% |
Conversion(C) | 4 | $0 | 0.0% |
Insider activity at DICE Therapeutics, Inc. shows mixed signals across all time. While $116.0M in purchases indicates some executive confidence,$122.1M in sales balances the picture, resulting in a modest net flow of -$6.1M.13 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Ventures Ii, Lp Northpond, has transacted $115.9M during this period.